Sterling Biotech Limited - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 1985.
1985 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Sterling Biotech Limited

Sterling Biotech Limited, a active public limited company, was established on 23 March 1985 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L51900MH1985PLC035738. Registered under ROC Roc Mumbai. it is listed on BSE: 512299. It has an authorized capital of ₹2,800.00 Cr and a paid-up capital of ₹643.35 Cr.

Formerly known as Sterling Tea & Indutries Limited, Pluto Exports & Consultants Limited. It upholds a compliant status. In 2024, it reported revenue of ₹476.71 Cr and a net worth of ₹879.42 Cr. Employing 249 professional, Its leadership includes Narayan Tripunithura Mahadeva (Director), Perumal Gandhi (Director), Alok Kumar Garg (Nominee Director). Past directors included Rama Subramaniam Gandhi, Narayan Tripunithura Mahadeva, Perumal Gandhi. It holds ₹703.90 Cr open charges and ₹21,758.44 Cr settled loans. Its latest AGM occurred on 17 September 2025, with the balance sheet filed on 31 March 2025. It is based at Office No. 601, Windfall Building,, Sahar Plaza Complex, Near Hotel Kohinoor, (Andheri East), Mumbai, Maharashtra, 400059.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L51900MH1985PLC035738

  • Registration Number

    035738

  • Incorporation Date

    23 March 1985

  • Authorized Capital

    ₹2,800.00 Cr

  • Paid-Up Capital

    ₹643.35 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Listed (BSE: 512299)

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2,800.00 Cr
  • Paid Up Capital ₹ 643.35 Cr
  • Company Age 40 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 703.90 Cr
  • Satisfied Charges ₹ 21,758.44 Cr
  • Revenue Growth **** 7.51%
  • Profit Growth **** -100.32%
  • Ebitda **** 12.73%
  • Net Worth -2.14%
  • Total Assets **** 0.46%
Company report

Sterling Biotech Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sterling Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sterling Biotech Limited?
Current Directors
Name Designation Appointment Date Status
Narayan Tripunithura Mahadeva Director 30 Sep 2023 Current
Perumal Gandhi Director 17 Nov 2022 Current
Alok Kumar Garg Nominee Director 29 Aug 2024 Current
Monisha Prabhu Macedo Nominee Director 24 Mar 2025 Current
Vishal Jyotindra Gor Nominee Director 29 Aug 2024 Current
Aftab Mathur Nominee Director 25 Jun 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 30 Sep 2023 Past
Pramod Abcsdd Director 24 Dec 2024 Past
Pramod Abcsdd Director 10 Oct 2024 Past
Pramod Abcsdd Director 29 Aug 2024 Past
Pramod Abcsdd Director 08 Sep 2021 Past
Pramod Abcsdd Managing Director 17 Nov 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sterling Biotech.

Sterling Biotech Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 7.51% increase. The company also saw a substantial fall in profitability, with a 100.32% decrease in profit. The company's net worth dipped by a decrease of 2.14%.

Sterling Biotech revenue growth over time
Sterling Biotech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 7.51%
*******
*******
*******
*******
Revenue from Operations
*******
 5.43%
*******
*******
*******
*******
Total Assets
*******
 0.46%
*******
*******
*******
*******
Profit or Loss
*******
 -100.32%
*******
*******
*******
*******
Net Worth
*******
 -2.14%
*******
*******
*******
*******
EBITDA
*******
 12.73%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sterling Biotech?

In 2024, Sterling Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹7,039,000,000.00

Satisfied Charges

₹217,584,414,000.00

Charges Breakdown by Lending Institutions
  • Others : 667.00 Cr
  • State Bank Of India : 22.50 Cr
  • Hdfc Bank Limited : 14.40 Cr
Latest Charge Details
Date Lender Amount Status
18 Sep 2025 Others ₹95.00 Cr Open
18 Sep 2025 Others ₹572.00 Cr Open
28 Nov 2023 State Bank Of India ₹22.50 Cr Open
19 Oct 2023 Hdfc Bank Limited ₹14.40 Cr Open
03 Oct 2023 Others ₹24.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Sterling Biotech?

Sterling Biotech has a workforce of 249 employees as of Mar 27, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sterling Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sterling Biotech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sterling Biotech
Recent Activity within the Organization
  • Director Appointment

    Progress on Nikita Ashok Suyani was appointed as a Company Secretary was appointed as a Company Secretary on 15 Dec 2025 & has been associated with this company since 3 months 3 days . was documented.

  • Charges

    The activity A charge with Others amounted to Rs. 95.00 Cr with Charge ID 101161944 was registered on 18 Sep 2025. was completed.

  • Charges

    The activity A charge with Others amounted to Rs. 572.00 Cr with Charge ID 101161938 was registered on 18 Sep 2025. was completed.

  • Annual General Meeting

    Progress on Sterling Biotech Limited last Annual general meeting of members was held on 17 Sep 2025 as per latest MCA records. was documented.

  • Director Appointment

    Anil Shantilal Inani was appointed as a CFO was appointed as a CFO on 27 Jun 2025 & has been associated with this company since 8 months 21 days . was recorded as a recent event.

  • Director Appointment

    Aftab Mathur was appointed as a Nominee Director was appointed as a Nominee Director on 25 Jun 2025 & has been associated with this company since 8 months 23 days . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Sterling Biotech Limited?

The CIN of Sterling Biotech Limited is L51900MH1985PLC035738.

Where is Sterling Biotech Limited headquartered?

Sterling Biotech Limited is headquartered at Office No. 601, Windfall Building,, Sahar Plaza Complex, Near Hotel Kohinoor, (Andheri East), Mumbai, Maharashtra, 400059.

When was Sterling Biotech Limited incorporated?

Sterling Biotech Limited was incorporated on 23 March 1985.

Who are the current directors of Sterling Biotech Limited?

The current directors of Sterling Biotech Limited are

What is the primary industry of Sterling Biotech Limited?

The primary industry of Sterling Biotech Limited is Manufacturing.

Is Sterling Biotech Limited a listed company?

Sterling Biotech Limited is listed. It is listed on BSE: 512299.

What is the capital structure of Sterling Biotech Limited?

The authorized capital of Sterling Biotech Limited is ₹2,800.00 Cr, and the paid-up capital is ₹643.35 Cr.

What is the compliance status of Sterling Biotech Limited?

The compliance status of Sterling Biotech Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available